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and Synergy (p< 0.001).
Conclusions: The current ex vivo swine shunt model demonstrated the least throm-
bogenicity in permanent polymer XIENCE as compared to 4 biodegradable polymer
DES, which emphasizes its acute protective effect against thrombus formation.TCT-437
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Background: Transcatheter mitral annuloplasty (TMA) has been introduced as
alternative to open-heart surgery. The Cardioband TMA (Valtech Cardio, Israel) is a
ﬂexible band delivered over the posterior annulus by multiple anchors. The implant
size is adjusted to reduce the annulus dimension. The aim of the study is to compare
the biomechanical impact of the Cardioband TMA vs. a surgical annuloplasty pro-
cedure (SAP) with a rigid-complete ring.
Methods: A computational model of pathological functional mitral valve (MV) was
derived from cardiac MRI, to analyse effects during systolic closure following TMA
and SAP. The TMA was simulated by placing 14 anchors (8mm spacing) in the
posterior annulus, as per device speciﬁcations. An homogeneous 33% shortening of
the device was imposed, as from clinical data. The SAP was simulated modelling the
annulus into the surgical ring shape. Closure dynamics, leaﬂets and annular conﬁg-
uration and stresses were compared.
Results: MV area was reduced from 16.0 to 7.8 and 6.5cm2 with TMA and SAP,
respectively. Coaptation length (CL) increased from 0 to 3.5 and 4.3mm respectively.
Leaﬂet and the annular peak stresses at baseline were both equal to 800kPa. Following
TMA they decreased to 250 and 500kPa, while following SAP leaﬂet stresses
decreased to 450kPa but annular stresses increased over 800kPa.B128 JACC Vol 64/11/Suppl B jConclusions: SAP was associated with slightly higher CL and reduced MV area, but
induced higher stresses on the mitral annulus. TMA resulted in an effective
improvement of valve competence while avoiding mechanical overloads. These
promising outcomes are under further clinical evaluation.
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Background: Atherosclerotic plaque rupture remains the leading cause of acute
cardiovascular syndromes and the need for plaque stabilizing interventions is high. In
the last 10 years, cryotherapy was investigated as a new technology to treat vascular
disease. Previous studies focused mainly on treatment and prevention of restenosis in
peripheral arterial disease. The efﬁciency of cryotherapy on stabilizing atherosclerotic
plaques has never been described. The purpose of the present study was to evaluate the
effect of catheter-based cryotherapy on atherosclerotic plaque composition in a rabbit
model of atherosclerosis.
Methods: Twenty-four New-Zealand White rabbits were fed a 0.3%-cholesterol
supplemented diet for 24 weeks. At three predeﬁned sites of the atherosclerotic
thoracic aorta, balloon angioplasty applying either single dose, double dose
cryotherapy or control inﬂation was performed. Rabbits were continued on
cholesterol-supplemented diet for 1 day (acute) or 4 weeks (chronic). After
euthanasia and preparation for histology, sections were analyzed for apoptosis,
content of smooth muscle cells (SMC), collagen, and macrophages, endothelium
and calciﬁcations.
Results: One day after cryotherapy, apoptotic cell death of SMCs and endothelial
cells (ECs) was observed, whereas macrophages were unaffected. Four weeks after
cryo-treatment, the amount of SMCs was restored and the EC layer was regener-
ated. Moreover, the thickness and type I collagen content of the ﬁbrous cap was
increased, indicative of a more stable plaque. The percentage of macrophages was
slightly increased in deep layers, but unaltered in luminal layers of the plaque. The
frequency of plaque calciﬁcations was increased and signs of positive remodeling
were observed.
Conclusions: For the ﬁrst time in atherosclerotic lesions, this present study demon-
strated that cryotherapy is safe and appears to stabilize atherosclerotic plaques in a
rabbit model. This warrants further investigation.
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Background: The Multilayer Flow Modulator (MFM) (Cardiatis, Isnes, Belgium) is a
self-expandable mesh of cobalt alloy wires used for the treatment of aortic aneurysms.
We assessed the impact of design thread count and duration of implantation on the
biocompatibility of the MFM in porcine animal models.
Methods: Eight mini-piglets received 26 MFM (12 with 56 thread design, 14 with
80 or 96 threads) in iliac, carotid, and renal arteries. Animals were sacriﬁced/
explanted at 1, 3, and 6 months, when histological and ultrastructural analyses
were conducted.
Results: The MFM was successfully deployed in 25 of 26 cases. Percentage ste-
nosis was 16.9%  5.1% for the 56 thread devices versus 33.4%  10.2% for the
80-96 thread devices (p ¼ 0.001) at 3 months, and 21.7%  9.9% for the 56 thread
devices versus 33.6%  12.4% for the 80-96 thread devices (p ¼ 0.004) at 6
months. The 5 devices selected for SEM examination were well deployed, inte-
grated into the vessel wall and endothelialized (Figure 1), and had patent side
branches.September 13–17, 2014 j TCT Abstracts/New Devices and Innovation
